When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - Gilead: Strategic Update - Focus On 'Defend/Extend' HIV Franchise
Merck & Company Inc.
Background
This is Part 2 of a 2-part set of articles about Gilead (GILD); Part 1 focused on its remdesivir ("RDV") for COVID-19.
There is probably more going on at GILD than the focus on RDV in GILD's recent Q1 earnings report and conference call could allow to be discussed. The 10-Q provided little new information.
In this commentary, I thought that a few comments on what might be called an internal restructuring of GILD were in order, followed by some details of ViiV's growth strategy in HIV and GILD's multi-faceted defense and